Ted Crandall
Analyst · John Inch, Deutsche Bank. Please go ahead
Thanks, Keith and good morning everyone. I’ll start with page four, first quarter key financial information. Sales in the quarter were $1.574 billion, 1.1% lower than Q1 last year. Organic sales growth as Keith mentioned was 2.1%, a current translation reduced sales in the quarter by 3.4 points. Segment operating margin was very strong at 22%, up 140 basis points from Q1 last year, despite the small sales decline. The year-over-year margin increase was primarily due to the higher organic sales, favorable mix and a strong productivity quarter, partially offset by a modest increase in spending. General corporate net expense was $23 million in Q1, up about $1 million compared to a year ago. Adjusted earnings per share were $1.64, up $0.17 or 12% compared to the first quarter of last year. The adjusted effective tax rate in the quarter was 26% compared to 27.8% in Q1 last year. The 26% adjust effective rate in Q1 reflects the retroactive extension of the U.S. R&D tax credit for calendar year 2014. Free cash flow for Q1 was $233 million, a very good result for the first quarter and strong start for the year. Free cash flow conversion on adjusted income was 103% in Q1. Our trailing four quarter return on invested capital was 30.1%. There were couple of items not shown here. Average diluted shares outstanding in the quarter were $136.9 million that’s down about 2.5% compared to last year. And during the first quarter, we’ve repurchased 1.55 million shares at a cost of about $167 million. At the end of the quarter, we had 884 million remaining under our share repurchase authorization. The next two slides presents the sales and operating margin performance of each segment, I’ll start with the Architecture & Software segment on page five. On the left side of this chart, you can see that Architecture & Software segment sales were $708 million in Q1 an increase of 1.7% compared to Q1 last year. Organic growth was 5.1%. Moving to the right side of the chart, on 5.1% organic growth A&S margins were 31.3% up 90 basis points compared to Q1 last year. With the improved margin primarily due to the higher organic sales and a good productivity quarter. Now turning to page six, a similar view for the Control Products & Solutions segment. In the first quarter, Control Products & Solutions segment sales were down 3.3% year-over-year and essentially flat year-over-year on an organic basis. Organic growth for product sales in the segment was a solid 3.3%. Solutions and services sales were down 2.8% organically. That was actually a bit better than we expected given the low starting backlog. The book-to-bill in Q1 for solutions and services was 1.13 that’s pretty healthy and starts to rebuild the backlog that we need to drive growth in the balance of this year in this part of our business. CP&S delivered very good operating margin in Q1 at 14.5%, up 150 basis points compared to last year, despite the decline in reported sales. The earnings conversion on the negative currency impact was modest in this segment. Mix was somewhat favorable. Project margins were better in the solutions and services businesses and that was particularly strong productivity quarter. Page seven, provides a geographic breakdown of our sales and shows organic growth results for the quarter. The organic sales growth in Q1 was driven largely by Latin America with Canada and Asia Pacific also contributing. The U.S. was flat year-over-year in Q1 with 3% growth than the product businesses and a 4% decline in the solutions and services businesses. The decline in solutions and services was expected and consistent with our comments last year regarding a low beginning backlog. The underlying market in the U.S. remains very healthy and that was reflected an orders growth in the U.S. in the mid-single digits. Canada saw 8% growth that was partly about project timing and an easy comparison in the last year. But with the exception of the Oil Sands, we’re seeing some pickup in most other markets in Canada. EMEA was down 1% organically, it was somewhat unusual quarter for the region in that sales and Western Europe were actually up 1.6%. However that was more than offset by declines in emerging countries particularly South Africa and to a lesser extent Turkey and Russia. Asia Pacific was up 2.9%, growth was pretty broad based across the region with the exception of China which was down 2%. I would attribute the decline in China more to project timing than any change in underlying market conditions. China orders in the quarter were up mid-single digit. India organic growth in Q1 was 9%, so we continue to see improvement in that market. Keith already talked about Latin America, so I’ll close out this slide, I’ll just add that overall for emerging markets, organic growth was 4.4% and that obviously led by Latin America. And that takes us to the fiscal year ’15 guidance slide. As Keith mentioned, we’re revising our full year guidance. We’re reducing full year sales guidance primarily to reflect a much more significant headwind from currency and to a lesser step, less optimism about the high end of the sales range. We’re dropping the high end of the sales range primarily due to the very significant decline in oil prices, but also because we’re continuing to see forecasts for IT and GDP be revised downward in most regions although the forecast still call for growth in 2015 that’s similar to 2014. Our previous guidance call for reported sales of approximately 6.8 billion at the midpoint, in the original guidance, we expected currency to reduce sales by 1.8 points and we expect organic growth of 2.5% to 6.5%. Now for the full year, because the dollar is continued to appreciate against the broad basket of currencies, we expect currency to reduce sales by 4.5 points. That difference in currency impact from previous to current guidance results in a reduction and reported sales for the full year of about $180 million. We’re also reducing the high end of organic growth from 6.5% to 5.5%. We’re maintaining the low end of organic growth to 2.5% that will drop organic growth at the midpoint by 1.5 point. We’re revising EPS guidance from the previous 655 to 695 to a new range of $6.50 to $6.80. From the old to the new midpoint, EPS will be down by $0.10, that’s a very modest EPS decline on a roughly $200 million sales decline coupling the currency impact and the organic sales change. In part based on our performance in Q1, we now expect slightly higher operating margins for the full year about 20 basis points, but still about 21%. We’re projecting an adjusted effective tax rate of 26.5%, half a point lower than previous guidance and largely due to the R&D tax credit. We didn’t plan on the extension of the R&D credit in the original guidance. Those factors allow us to absorb a pretty large drop in the sales guidance with a relatively small impact on EPS. We continue to expect converted by 100% of net come to free cash flow and that’s couple of items not shown here, we continue to expect general corporate net expense to be approximately $80 million for the full year and we continue to expect average diluted shares outstanding to be about 136 million for the full year. The last slide is a walk for adjusted EPS from the previous to the revise guidance midpoint. Starting on the last slide, the previous guidance for adjusted EPS midpoint was $6.75. The big change as you can see here is currency compared to prior guidance with the additional top line translation headwind of a 180 million. All in, we expect a related earnings impact to reduce adjusted EPS by about $0.25. A little higher operating market is more than offsetting the impact of a half point lower organic sales growth at the new midpoint and the net effect adds about $0.09 to quarter. Lower tax rate and share counts add an additional $0.06 compared to prior guidance that gets us to the new midpoint of $6.65. And with that I’ll turn it over to Rondi to begin Q&A.